4//SEC Filing
KELLY MICHAEL GERALD 4
Accession 0001181431-05-062611
CIK 0001118361other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:15 PM ET
Size
12.2 KB
Accession
0001181431-05-062611
Insider Transaction Report
Form 4
RENOVIS INCRNVS
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
- Sale
Common Stock
2005-11-17$13.64/sh−1,000$13,640→ 50,800 total
Footnotes (1)
- [F1]The sales that occurred on November 17, 2005 represent sales that should have occurred on June 16, 2005, July 18, 2005, August 16, 2005, September 16, 2005, October 17, 2005 and November 16, 2005 pursuant to Dr. Kelly's 10b5-1 Plan but did not occur because of broker error. In accordance with the broker's policy and procedures for correcting trade errors, a trade correction was executed on November 17, 2005.
Documents
Issuer
RENOVIS INC
CIK 0001118361
Entity typeother
Related Parties
1- filerCIK 0001278455
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:15 PM ET
- Size
- 12.2 KB